The government Tuesday said that generic drugs have resulted in benefits worth Rs 2,000 crore for common people.
Minister of State for Chemicals and Fertilisers Mansukh Mandaviya said all manufacturers of scheduled medicines, branded or generic, have to sell their products within the ceiling price fixed by the National Pharmaceutical Pricing Authority (NPPA). Local taxes would also be applicable on the medicines.
During the Question Hour in the Lok Sabha, he said generic drugs have helped in benefits worth Rs 2,000 crore for common people.
He also mentioned various steps taken by the government, including fixing ceiling prices for over 1,000 medicines and reducing medical costs for cardiac patients.
"The medicines sold under the Pradhan Mantri Bhartiya Janaushadi Pariyojana (PMBJP) are generic and normally cheaper by 50-90 per cent of average price of top three brands of corresponding medicines," the minister said.
The minister also urged members to encourage setting up of more Janaushadi outlets.
As many as 5,028 PMBJP kendras were opened during the last five years.
Currently, the product basket of PMBJP comprises 900 medicines and 154 surgicals and consumable items. Out of them, 714 medicines and 53 surgicals are presently available for sale at the kendras, the minister said.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
